Labcorp’s pathologists will use the software to review, interpret and manage digital images of slides for primary diagnosis.

Labcorp’s Q4 results came in below Wall Street’s revenue expectations, leading to a negative market reaction, while ...

Labcorp expanded its partnership with PathAI to offer its FDA-cleared digital pathology platform at the life science giant’s U.S. network of anatomical pathology labs and participating hospitals.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with PathAI to deploy AISight® Dx 1, an FDA-cleared digital pathology ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® pTau-181 test, the first and only blood test ...

A large regional health system has saved more than $5 million a year on labor and supplies—and even more with capital expense avoidance—by partnering with Labcorp. Within a period of one year, Labcorp ...

Feb 17 (Reuters) - Laboratory services provider Labcorp forecast annual profit above Wall Street estimates on Tuesday, ...

Clemson University announced today a strategic collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services, to improve healthcare access, expand educational ...

Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...

The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.

LH heads into its Q4 earnings report with rising revenue and EPS expectations, driven by Diagnostics momentum, acquisitions ...

19 analysts have issued ratings. Wall Street analysts rate LH as Bullish on average, for a Wall Street consensus of buy. View LH’s ratings here. Labcorp Holdings Inc. is currently listed on NYSE under ...